Biomind Labs

BMND.F

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

Biomind Labs is a small biotech company focused on developing medicines based on psychedelic compounds, mainly DMT (dimethyltryptamine). It is working on treatments for brain and nervous system conditions, such as depression and neurological disorders. The company is in the research and development stage, meaning it does not yet sell approved products to patients.

Biomind Labs makes very little revenue right now because its drugs are still being tested in clinical trials. It operates primarily in Canada and Latin America, giving it access to research environments with different regulatory frameworks. The company's main risk is that it depends heavily on raising outside funding to keep running, and there is no guarantee its experimental treatments will pass clinical trials or receive regulatory approval for sale.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

no trend

Data not available

Profit after running costs

Operating Margin

N/A

no trend

Data not available

Return on the money invested

ROCE

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

no trend

Data not available

Profit growth

EPS YoY

N/A

no trend

Data not available

How steady the profit is

EPS Consistency

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

no trend

Data not available

Spare cash per sale

FCF Margin

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

no trend

Data not available

Covers its interest

Interest Cover

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial